TAIHUSNOW CO.,LTD.
838262
Guangdong Brandmax Marketing
300805
Guangdong Transtek Medical Electronics
300562
Suzhou Kingswood Education Technology
300192
Broadex Technologies
300548
CN Stock MarketDetailed Quotes
000627 Hubei Biocause Pharmaceutical
- 5.06
- +0.20+4.12%
Trading Dec 16 14:50 CST
25.00BMarket Cap-32.44P/E (TTM)
5.28High4.80Low3.45MlotVolume4.87Open4.86Pre Close1.75BTurnover7.57%Turnover RatioLossP/E (Static)4.94BShares5.4252wk High1.15P/B23.04BFloat Cap1.6152wk Low5.35Limit Up4.55BShs Float16.97Historical High4.37Limit Down9.88%Amplitude0.45Historical Low--Dividend TTM5.08Avg Price1.49MlotAsk--Div YieldTTM100Lot Size1.85MlotBid
Hubei Biocause Pharmaceutical News
Tianmao Group: Announcement on the appointment of the company\'s senior management
Tianmao Group: Tianmao Industrial Group Co., Ltd. voluntary information disclosure announcement on the premium income of Guohua Life Insurance Co., Ltd.
Tianmao Group: Written Review Opinions of the Supervisory Committee on the 2024 Third Quarterly Report (online)
Tianmao Group: Announcement on the death of the company\'s vice chairman and senior management
Tianmao Group: Tianmao Industrial Group Co., Ltd. voluntary information disclosure announcement on the premium income of Guohua Life Insurance Co., Ltd.
Tianmao Group: Tianmao Industrial Group Co., Ltd. voluntary information disclosure announcement on the premium income of Guohua Life Insurance Co., Ltd.
Tianmao Group: Announcement on the appointment of the company\'s senior management and other personnel
Tianmao Group: Semi-annual Non-Operating Capital Occupancy and Other Related Capital Transactions Summary
Tianmao Group: 2024 Semi-Annual Financial Report
Tianmao Group: Semi-Annual Financial Report
Tianmao Group: Legal Opinion of Tianmao Group\'s 2024 Third Extraordinary General Meeting of Shareholders
Tianmao Group: Announcement of Resolutions of the 2024 Third Extraordinary General Meeting of Shareholders
Tianmao Group: Announcement on the completion of the general election of the Board of Directors and the Board of Supervisors
Hubei Biocause Pharmaceutical: Tianmao Industrial Group Co., Ltd. voluntary information disclosure announcement regarding the premium income of China Best Life Insurance Co., Ltd.
Hubei Biocause Pharmaceutical: Announcement Regarding Revision of the Articles of Association, Shareholders' Meeting Rules, Board of Directors Meeting Rules, and Board of Supervisors Meeting Rules.
Hubei Biocause Pharmaceutical: The board of directors nomination committee of Hubei Biocause Pharmaceutical's 9th session has reviewed the qualifications of director candidates.
Hubei Biocause Pharmaceutical: Announcement Regarding the Election of Employee Representatives to the Tenth Supervisory Board
Hubei Biocause Pharmaceutical: Board of Directors Meeting Rules (August 2024)
Hubei Biocause Pharmaceutical: Notice about convening the third temporary shareholders' meeting in 2024.
Hubei Biocause Pharmaceutical: Tianmao Industrial Group Co., Ltd. voluntary information disclosure announcement regarding the premium income of China Best Life Insurance Co., Ltd.
